SCHEMBL23180882

SCHEMBL23180882

c1ccc(-c2cccc(-c3cccc(N(c4ccc(-c5ccc(-c6cccc(-c7ccc8ccccc8c7)c6)cc5)cc4)c4ccc(-c5ccc6c(c5)oc5ccccc56)cc4)c3)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 1/20 0.42
▸ PLA2G2A P14555 3/20 0.39
▸ PLA2G4A P47712 3/20 0.39
▸ MMP12 P39900 1/20 0.38
▸ MMP13 P45452 1/20 0.38
▸ PLA2G10 O15496 1/20 0.36
▸ HSD17B1 P14061 2/20 0.36
▸ HSD17B2 P37059 2/20 0.36
▸ AHR P35869 2/20 0.36
▸ PGR P06401 1/20 0.36
▸ ANO1 Q5XXA6 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ CYP1A1 P04798 2/20 0.35
▸ CYP1B1 Q16678 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24842286 1.00 HCRTR1 (0.42) HCRTR1PLA2G2APLA2G4AMMP12MMP13
SCHEMBL23180164 1.00 HCRTR1 (0.42) HCRTR1PLA2G2APLA2G4AMMP12MMP13
SCHEMBL24841416 1.00 HCRTR1 (0.42) HCRTR1PLA2G2APLA2G4AMMP12MMP13
SCHEMBL23180849 1.00 HCRTR1 (0.42) HCRTR1PLA2G2APLA2G4AMMP12MMP13
SCHEMBL23179640 1.00 HCRTR1 (0.42) HCRTR1PLA2G2APLA2G4AMMP12MMP13
SCHEMBL24919458 1.00 HCRTR1 (0.42) HCRTR1PLA2G2APLA2G4AMMP12MMP13
SCHEMBL23179401 1.00 HCRTR1 (0.42) HCRTR1PLA2G2APLA2G4AMMP12MMP13
SCHEMBL24919750 0.99 HCRTR1 (0.41) HCRTR1PLA2G2APLA2G4AMMP12MMP13
SCHEMBL23224691 0.99 HCRTR1 (0.43) HCRTR1PLA2G2APLA2G4AMMP12MMP13
SCHEMBL23224731 0.99 HCRTR1 (0.43) HCRTR1PLA2G2APLA2G4AMMP12MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230006136-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-05 — — US disclosed
WO-2021060239-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2021-04-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230006136-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, POU2F1 HCRTR1 3540/4885PLA2G2A 4651/4885PLA2G4A 4762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback